Sinovac Biotech Ltd
F:SVQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sinovac Biotech Ltd
F:SVQ
|
CN |
|
D
|
DFI Retail Group Holdings Ltd
LSE:DFIJ
|
HK |
|
W
|
W W Grainger Inc
F:GWW
|
US |
|
E
|
Ecolab Inc
DUS:ECJ
|
US |
|
P
|
Powszechny Zaklad Ubezpieczen SA
WSE:PZU
|
PL |
|
NEXE Innovations Inc
F:NX5
|
CA |
|
Banimmo SA
F:L8J
|
BE |
|
NovaBridge Biosciences
F:0VY
|
US |
|
N
|
Nanoco Group PLC
OTC:NNOCF
|
UK |
|
I
|
International Bancshares Corp
F:IB4
|
US |
|
G
|
Glenveagh Properties PLC
XMUN:GVR
|
IE |
|
Angus Energy PLC
F:A3R
|
UK |
|
S
|
St Barbara Ltd
OTC:STBMF
|
AU |
|
Zalaris ASA
F:81Y
|
NO |
|
Menicon Co Ltd
OTC:MNNLF
|
JP |
|
A
|
Artisan Consumer Goods Inc
OTC:ARRT
|
US |
Bankruptcy Probability
Sinovac Biotech Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Sinovac Biotech Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
|
Sinovac Biotech Ltd
NASDAQ:SVA
|
644.7m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
521B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
258.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
216.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
139.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
99.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
103.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Sinovac Biotech Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Sinovac Biotech Ltd has total debt of 233.1m USD. This includes both short-term (0 USD) and long-term (233.1m USD) debt.
You can find a full breakdown on its Balance Sheet.
